U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 22:39:49 GMT 2025
Edited
by admin
on Mon Mar 31 22:39:49 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
4TVX2I407K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TUMOR NECROSIS FACTOR-.ALPHA. HUMAN (PLASMA DERIVED, SOLUBLE FORM)
Common Name English
CACHECTIN
Preferred Name English
TNF-.ALPHA.
Common Name English
TUMOR NECROSIS FACTOR-.ALPHA. HUMAN (SOLUBLE FORM)
Common Name English
TUMOR NECROSIS FACTOR-.ALPHA. (SOLUBLE FORM)
Common Name English
Tumor necrosis factor alpha [WHO-DD]
Common Name English
TUMOR NECROSIS FACTOR .ALPHA. HUMAN (SOLUBLE FORM)
Common Name English
TUMOR NECROSIS FACTOR-ALPHA
Common Name English
TUMOR NECROSIS FACTOR-.ALPHA.
Common Name English
Code System Code Type Description
CAS
308079-78-9
Created by admin on Mon Mar 31 22:39:49 GMT 2025 , Edited by admin on Mon Mar 31 22:39:49 GMT 2025
PRIMARY
SMS_ID
100000137544
Created by admin on Mon Mar 31 22:39:49 GMT 2025 , Edited by admin on Mon Mar 31 22:39:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID4040634
Created by admin on Mon Mar 31 22:39:49 GMT 2025 , Edited by admin on Mon Mar 31 22:39:49 GMT 2025
PRIMARY
MESH
D014409
Created by admin on Mon Mar 31 22:39:49 GMT 2025 , Edited by admin on Mon Mar 31 22:39:49 GMT 2025
PRIMARY
PUBCHEM
161495
Created by admin on Mon Mar 31 22:39:49 GMT 2025 , Edited by admin on Mon Mar 31 22:39:49 GMT 2025
PRIMARY
FDA UNII
4TVX2I407K
Created by admin on Mon Mar 31 22:39:49 GMT 2025 , Edited by admin on Mon Mar 31 22:39:49 GMT 2025
PRIMARY
EVMPD
SUB75902
Created by admin on Mon Mar 31 22:39:49 GMT 2025 , Edited by admin on Mon Mar 31 22:39:49 GMT 2025
PRIMARY
From To
3_69 3_101
2_69 2_101
1_69 1_101
Glycosylation Type HUMAN
Glycosylation Link Type Site
O 1_3
O 2_3
O 3_3
Related Record Type Details
Structure of BMS-561392
INHIBITOR -> TARGET
SELECTIVE
Structure of THALIDOMIDE
INHIBITOR -> TARGET
BINDING
Structure of N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N?-[4-[[2-(phenylamino)-4-pyrimidinyl]oxy]-1-naphthalenyl]urea
INHIBITOR OF RELEASE->TARGET
THP cells
IC50
ANTI-TNF-.ALPHA (OVINE, FAB)
INHIBITOR -> TARGET
Structure of Roflumilast N-oxide
INHIBITOR OF RELEASE->TARGET
In human PBMCs
IC50
ADALIMUMAB
INHIBITOR -> TARGET
BINDING
Structure of CEPHARANTHINE
INHIBITOR -> TARGET
TANFANERCEPT
INHIBITOR -> TARGET
Structure of ELSIBUCOL
INHIBITOR OF RELEASE->TARGET
REMTOLUMAB
INHIBITOR -> TARGET
OZORALIZUMAB
INHIBITOR -> TARGET
APL-1
INHIBITOR OF EXPRESSION->TARGET
Reduces the expression of inflammatory cytokines
Structure of Isomiosamine
INHIBITOR -> TARGET
Adalimumab Fosimdesonide
INHIBITOR -> TARGET
ETANERCEPT
INHIBITOR -> TARGET
BINDING
Structure of N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N?-[4-[[2-(phenylamino)-4-pyrimidinyl]oxy]-1-naphthalenyl]urea
INHIBITOR -> TARGET
dU937 cells
IC50
CERTOLIZUMAB PEGOL
INHIBITOR -> TARGET
BINDING
Licaminlimab
INHIBITOR -> TARGET
AFAMITRESGENE AUTOLEUCEL
T-CELLS->EXPRESSED PROTEIN
upon activation
Efsudenermin Alfa
INHIBITOR -> TARGET
Structure of VADIMEZAN
ACTIVATOR -> TARGET
NERELIMOMAB
INHIBITOR -> TARGET
Structure of APREMILAST
INHIBITOR -> TARGET
Structure of DELMITIDE
INHIBITOR OF EXPRESSION->TARGET
CERTOLIZUMAB
INHIBITOR -> TARGET
Structure of LEO-39652
INHIBITOR OF RELEASE->TARGET
IC50
PLACULUMAB
INHIBITOR -> TARGET
Structure of ISOINDOLIN-1,3-DITHIONE
INHIBITOR OF EXPRESSION->TARGET
AFELIMOMAB
INHIBITOR -> TARGET
Structure of 7-Chloro-2-(2,5-difluorophenyl)-4-oxo-4H-1-benzopyran-3-carboxylic acid
INHIBITOR -> TARGET
IN-VIVO
Structure of LENALIDOMIDE
INHIBITOR -> TARGET
Structure of EDRATIDE
INHIBITOR OF EXPRESSION->TARGET
Structure of CAMOBUCOL
INHIBITOR -> TARGET
Structure of AN-0128
INHIBITOR -> TARGET
Inhibition of LPS-induced TNF-? release from human monocytes
Infliximab beta
INHIBITOR -> TARGET
IN-VIVO
INFLIXIMAB
INHIBITOR -> TARGET
BINDING
Structure of 2-(4-(4-CHLOROPHENOXY)-3,5-DIMETHYL-1H-PYRAZOL-1-YL)-4-(2-PYRIDINYL)PYRIMIDINE
MODULATOR->TARGET
Structure of Acetylcysteine
INHIBITOR -> TARGET
GOLIMUMAB
INHIBITOR -> TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:CALCULATED CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966